BIO/B - Bio-Rad Laboratories, Inc. Class B Summary, Stock Quote and News | Benzinga

Skip to main content

Market Overview

326.74 0 (0%)

After Hours 390.29 (%)

Data as of Sep 20, 2024

Prev. Close 326.74
Price Open
Volume 6
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade BIO.B stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

{{ story.title }} {{ story.author }}{{ story.created }}

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 Business WireApr 18, 2024
Bio-Rad's Chief Operating Officer Andrew Last to Retire Business WireApr 10, 2024
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results Business WireFeb 15, 2024
Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits PRNewswireFeb 08, 2023
Bio-Rad Reports Second-Quarter 2017 Financial Results MarketwiredAug 03, 2017
Bio-Rad to Report Second-Quarter 2017 Financial Results Thursday, August 3, 2017 MarketwiredJul 10, 2017
Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method MarketwiredJun 12, 2017
Bio-Rad Reports First-Quarter 2017 Financial Results MarketwiredMay 04, 2017
{{ story.title }} {{ story.author }}{{ story.created }}

Stryker: Cash Flow Returns On Investments Analysis Seeking AlphaAug 27, 2023
Stryker: Cash Flow Returns On Investments Analysis Seeking AlphaAug 27, 2023
Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript Seeking AlphaAug 03, 2023
Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript Seeking AlphaAug 03, 2023
Mawer Investment Management Quarterly Update - Q2 2023 Seeking AlphaJul 19, 2023
Mawer Investment Management Quarterly Update - Q2 2023 Seeking AlphaJul 19, 2023
Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Earnings Call Transcript Seeking AlphaMay 04, 2023
Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Earnings Call Transcript Seeking AlphaMay 04, 2023
Bio-Rad: Aggressively Buying In FY 2023 Seeking AlphaApr 13, 2023
Bio-Rad: Aggressively Buying In FY 2023 Seeking AlphaApr 13, 2023
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...